Abstract
Regulated upon activation in normal T cells, expressed, and secreted (RANTES) protein is abundantly expressed during atopic asthma, suggesting that it is an important mediator of this disease. The aim of this study was to evaluate the possible role of RANTES promoter polymorphisms in children with asthma. We genotyped 271 children with atopic asthma, 55 children with nonatopic asthma, and 253 control children for allelic determinants at two polymorphic sites in the promoter region at positions −403G>A and −28C>G by restriction fragment length polymorphism methods. There was no significant difference in genotype and allele frequencies of the RANTES −403G>A and −28C>G polymorphisms when the atopic asthma, nonatopic asthma, and control groups were compared. However, atopic asthmatic patients who were homozygous GG for the RANTES −28C>G tended to have lower PC20 methacholine than those carrying the wild genotype. In addition, a significantly lower PC20 was demonstrated for the homozygous haplotype −403A/−28G in asthmatic children. The polymorphisms within the RANTES promoter may have a disease-modifying effect in Korean children with asthma.
Similar content being viewed by others
References
Maddox L, Schwartz DA (2002) The pathophysiology of asthma. Annu Rev Med 53:477–498
Sengler C, Lau S, Wahn U, Nickel R (2002) Interactions between genes and environmental factors in asthma and atopy: new developments. Respir Res 3:7
Alam R (1997) Chemokines in allergic inflammation. J Allergy Clin Immunol 99:273–277
Schall TJ, Bacon K, Toy KJ, Goeddel DV (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669–671
Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176:587–592
Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krensky AM (1993) Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151:2601–2612
Kimata H, Yoshida A, Ishioka C, Fujimoto M, Lindley I, Furusho K (1996) RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J Exp Med 183:2397–2402
Venge J, Lampinen M, Hakansson L, Rak S, Venge P (1996) Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol 97:1110–1115
Lampinen M, Rak S, Venge P (1999) The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy 29:314–322
Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA (1999) Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro. Am J Pathol 155:591–598
Boyce JA (1997) The pathobiology of eosinophilic inflammation. Allergy Asthma Proc 18:293–300
McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN (1998) A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 8:339–342
Donlon TA, Krensky AM, Wallace MR, Collins FS, Lovett M, Clayberger C (1990) Localization of a human T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12. Genomics 6:548–553
Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S, Nakamura T, Nagai Y, Iwamoto A, Shioda T (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 96:4581–4585
Nickel RG, Casolaro V, Wahn U, Beyer K, Barnes KC, Plunkett BS, Freidhoff LR, Sengler C, Plitt JR, Schleimer RP, Caraballo L, Naidu RP, Levett PN, Beaty TH, Huang SK (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164:1612–1616
Fryer AA, Spiteri MA, Bianco A, Hepple M, Jones PW, Strange RC, Makki R, Tavernier G, Smilie FI, Custovic A, Woodcock AA, Ollier WE, Hajeer AH (2000) The −403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 1:509–514
Yao TC, Kuo ML, See LC, Chen LC, Yan DC, Ou LS, Shaw CK, Huang JL (2003) The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. J Allergy Clin Immunol 111:1285–1292
Al-Abdulhadi SA, Helms PJ, Main M, Smith O, Christie G (2005) Preferential transmission and association of the −403 G → A promoter RANTES polymorphism with atopic asthma. Genes Immun 6:24–30
Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ (2000) Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161:309–329
Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW (2004) Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 114:568–574
Backman A (1994) Skin tests for epidemiologic studies. Allergy 49:493–494
Brown WG, Halonen MJ, Kaltenborn WT, Barbee RA (1979) The relationship of respiratory allergy, skin test reactivity, and serum IgE in a community population sample. J Allergy Clin Immunol 63:328–335
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
Hedrick PW (1987) Gametic disequilibrium measures: proceed with caution. Genetics 117:331–341
Nelson PJ, Ortiz BD, Pattison JM, Krensky AM (1996) Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes. J Immunol 157:1139–1148
Moriuchi H, Moriuchi M, Fauci AS (1997) Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 158:3483–3491
Hizawa N, Yamaguchi E, Konno S, Tanino Y, Jinushi E, Nishimura M (2002) A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am J Respir Crit Care Med 166:686–690
Choi SY, Sohn MH, Yum HY, Kwon BC, Kim KE (2005) Correlation between inhalant allergen-specific IgE and pulmonary function in children with asthma. Pediatr Pulmonol 39:150–155
Yang EG, Kim WJ, Kwon BC, Choi SY, Sohn MH, Kim KE (2006) Relationship among pulmonary function, bronchial hyperresponsiveness, and atopy in children with clinically stable asthma. Lung 184:73–79
Takada T, Suzuki E, Ishida T, Moriyama H, Ooi H, Hasegawa T, Tsukuda H, Gejyo F (2001) Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population. Tissue Antigens 58:293–298
McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA, Boatin BA, Leitman SF, Detels R, Hajeer AH, Murphy PM (2000) Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 14:2671–2678
Acknowledgment
This study was supported by a faculty research grant (No. 6-2004-97) of Yonsei University College of Medicine for 2004.
Author information
Authors and Affiliations
Corresponding author
Additional information
Myung Hyun Sohn and Seung-Hyun Kim contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sohn, M.H., Kim, SH., Kim, KW. et al. RANTES Gene Promoter Polymorphisms Are Associated with Bronchial Hyperresponsiveness in Korean Children with Asthma. Lung 186, 37–43 (2008). https://doi.org/10.1007/s00408-007-9049-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-007-9049-3